Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes - Lewis, E J; Hunsicker, L G; Clarke, W R; Berl, T; Pohl, M A; Lewis, J B; Ritz, E; Atkins, R C; Rohde, R; Raz, I (N Engl J Med, 2001)